ARTICLE | Company News
AM-Pharma, Pfizer deal
May 18, 2015 7:00 AM UTC
Pfizer purchased a 17.5% equity stake in AM-Pharma and received an option acquire the remainder of the company. The option is exercisable upon completion of a Phase II trial of AM-Pharma’s recAP recom...